Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Assets: 2022-2025

Historic Assets for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $1.1 billion.

  • Immunocore Holdings' Assets rose 1.65% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1.65%. This contributed to the annual value of $1.0 billion for FY2024, which is 69.10% up from last year.
  • Immunocore Holdings' Assets amounted to $1.1 billion in Q3 2025, which was up 1.86% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Assets ranged from a high of $1.1 billion in Q3 2025 and a low of $526.8 million during Q4 2022.
  • In the last 3 years, Immunocore Holdings' Assets had a median value of $1.0 billion in 2024 and averaged $990.2 million.
  • Data for Immunocore Holdings' Assets shows a peak YoY soared of 69.10% (in 2024) over the last 5 years.
  • Immunocore Holdings' Assets (Quarterly) stood at $526.8 million in 2022, then climbed by 13.33% to $597.0 million in 2023, then surged by 69.10% to $1.0 billion in 2024, then grew by 1.65% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.0 billion during Q1 2025.